Labcorp believes in harnessing science to improve the health and lives of people with neurodegenerative diseases, such as Alzheimer’s and multiple sclerosis.
NfL is a well-studied blood biomarker test that is now widely available through Labcorp for assessing neuronal damage from neurodegenerative diseases and sports-related concussion.
Finding a way to diagnose Alzheimer's earlier and easier is a key goal for Labcorp.
Genetics can play a significant role in the development of certain neurodegenerative diseases. In some cases, genetic testing may help confirm a diagnosis.
While no single test can diagnose multiple sclerosis, lab tests may help doctors rule out other diseases and confirm a diagnosis.
The increasing prevalence of neurodegenerative diseases has fueled the need for advanced research into pharmaceutical solutions and related neuro biomarkers.
Characterized by progressive muscle loss and weakness, our tests can detect the genetic mutations that cause the most common forms.